Efficacy and Safety of Hypofractionated Radiotherapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme: A Systematic Review and Meta-Analysis
Background: Hypofractionated radiotherapy (HFR) is sometimes used in the treatment of glioblastoma multiforme (GBM). The efficacy and safety of HFR is still under investigation. The aim of this systematic review and meta-analysis was to provide a comprehensive summary of the efficacy and safety of H...
Main Authors: | Guixiang Liao, Zhihong Zhao, Hongli Yang, Xianming Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.01017/full |
Similar Items
-
HYPOFRACTIONATED RADIOTHERAPY PART OF MULTIMODALITY TREATMENT IN MULTICENTRIC GLIOBLASTOMA MULTIFORME: A CASE REPORT
by: Vanessa MOLDOVEANU, et al.
Published: (2018-12-01) -
Outcomes in Newly Diagnosed Elderly Glioblastoma Patients after Concomitant Temozolomide Administration and Hypofractionated Radiotherapy
by: Georges Noël, et al.
Published: (2013-09-01) -
Salvage Radiation Therapy for Patients With Relapsing Glioblastoma Multiforme and the Role of Slow Fractionation
by: I. Frank Ciernik, et al.
Published: (2020-12-01) -
Comparison of efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma
by: Jiahua Lyu, et al.
Published: (2019-07-01) -
A comparative study of hypofractionated and conventional radiotherapy in postmastectomy breast cancer patients
by: Kartick Rastogi, et al.
Published: (2018-01-01)